Article
Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical Study
2021-04-07
Abstract excerpt
<h4>Aims</h4> Cardiomyocyte-derived induced pluripotent stem cells (iPSCs) may represent a promising therapeutic strategy for severely damaged myocardium. This study aimed to assess the efficacy and safety of clinical grade human iPSC-derived cardiomyocyte (hiPSC-CM) patches and conduct a pre-clinical proof-of-concept analysis. <h4>Methods and results</h4> A clinical grade hiPSC line was established from periphe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 95ae0206-93dd-535e-8476-ba6842e6bab8
- DOI
- 10.1101/2021.04.07.438744
